Literature DB >> 28781794

A case of membranous glomerulopathy associated with lung cancer and review of the literature.

Aydin Aytekin1, Ahmet Ozet1, Irem Bilgetekin1, Betul Ogut2, Aydin Ciltas1, Mustafa Benekli1.   

Abstract

Membraneous nephropathy (MN) is the most commonly occurring nephrotic syndrome in adults as well as the most common paraneoplastic nephropathy associated with solid tumors, and it is mostly associated with gastrointestinal system and lung carcinomas. Accurate diagnosis is important as the treatment of paraneoplastic glomerulonephritis is very varied from that of idiopathic ones. In the current report, a case of a patient that was referred with proteinuria and edema and was diagnosed with lung cancer, and responded markedly to treatment of malignancy, with improvement of MN, is presented. Active cancer is present in all patients with paraneoplastic MN. In numerous patients, the paraneoplastic MN and cancer diagnoses are made within one year of each other. The treatment of paraneoplastic syndromes is usually associated with the treatment of primary malignancy. There are conflicting data on which treatment modality is more suitable. In conclusion, further studies are required in order to determine the actual incidence of cancer in patients with nephropathy, explain the physiopathological association between cancer and nephropathy and to determine the most suitable treatment approaches.

Entities:  

Keywords:  adenocarcinoma; lung cancer; membranous glomerulopathy; nephrotic syndrome; solid tumor

Year:  2017        PMID: 28781794      PMCID: PMC5532683          DOI: 10.3892/mco.2017.1295

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  17 in total

1.  Paraneoplastic glomerulopathies: new insights into an old entity.

Authors:  P M Ronco
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

Review 2.  Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis.

Authors:  Yeong-Hau H Lien; Li-Wen Lai
Journal:  Nat Rev Nephrol       Date:  2010-12-14       Impact factor: 28.314

3.  Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.

Authors:  C Lefaucheur; B Stengel; D Nochy; P Martel; G S Hill; C Jacquot; J Rossert
Journal:  Kidney Int       Date:  2006-08-30       Impact factor: 10.612

Review 4.  Glomerulopathies of neoplasia.

Authors:  J W Eagen
Journal:  Kidney Int       Date:  1977-05       Impact factor: 10.612

Review 5.  Nephrotic syndrome and neoplasia: our experience and review of the literature.

Authors:  Małgorzata Wągrowska-Danilewicz; Marian Danilewicz
Journal:  Pol J Pathol       Date:  2011       Impact factor: 1.072

6.  Effectiveness of radiation therapy in nephrotic syndrome associated with advanced lung cancer.

Authors:  Y Shikata; Y Hayashi; H Yamazaki; K Shikata; H Makino
Journal:  Nephron       Date:  1999       Impact factor: 2.847

7.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

8.  Small cell lung cancer with paraneoplastic nephrotic syndrome.

Authors:  E S Boon; A A Vrij; C Nieuwhof; J A van Noord; E Zeppenfeldt
Journal:  Eur Respir J       Date:  1994-06       Impact factor: 16.671

Review 9.  Glomerular diseases: membranous nephropathy--a modern view.

Authors:  Claudio Ponticelli; Richard J Glassock
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

10.  Recurrence of paraneoplastic membranous glomerulonephritis following chemoradiation in a man with non-small-cell lung carcinoma.

Authors:  Andrew R Crawford; Lance Dworkin; Kara Leonard; Humera Khurshid; Jaroslaw T Hepel
Journal:  Rare Tumors       Date:  2013-05-06
View more
  2 in total

1.  Membranous nephropathy in a patient with pulmonary tuberculosis infection and lung adenocarcinoma: a case report.

Authors:  Nobuhisa Morimoto; Kiyotaka Nagahama; Yukio Tsuura; Ayumi Terai; Madoka Tanabe; Megumi Otani; Shingo Shioji; Suguru Hirasawa; Shota Aki; Makoto Aoyagi; Hiroyuki Tanaka
Journal:  CEN Case Rep       Date:  2021-08-29

2.  Nivolumab-induced membranous nephropathy in a patient with stage IV lung adenocarcinoma.

Authors:  Keiko Wakabayashi; Satoko Yamamoto; Shigeo Hara; Momoko Okawara; Kumie Teramoto; Natsuko Ikeda; Yasuo Kusunoki; Masanobu Takeji
Journal:  CEN Case Rep       Date:  2021-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.